Bone markers in the management of metastatic bone disease

A. Lipton, L. Costa, S. M. Ali, L. M. Demers

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

Newer markers of bone formation and bone resorption are now available. Alone these new markers do not appear to be useful to diagnose metastatic bone disease. Several markers appear to be of prognostic importance and correlate with the extent of tumour in the skeleton. Serial monitoring of bone markers may be useful to monitor the efficacy of bisphosphonate and/or systemic therapy of both lytic and blastic bone metastases.

Original languageEnglish (US)
Pages (from-to)181-185
Number of pages5
JournalCancer Treatment Reviews
Volume27
Issue number3
DOIs
StatePublished - Jun 2001

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Bone markers in the management of metastatic bone disease'. Together they form a unique fingerprint.

Cite this